The Centers for Medicare and Medicaid Services (CMS) , open through Feb. 26, for four new breast cancer-related measures developed by Acumen, LLC. These include three quality measures and one episode-based cost measure intended to assess clinician performance in breast cancer screening and diagnosis and improve patient outcomes. An will be held Feb. 13, 3–4pm ET.
The codes are:
- Breast Cancer Screening Recall Rate Quality Measure (Outcome).
- Breast Cancer Screening with an Eventual Breast Cancer Diagnosis: Positive Predictive Value 1 (PPV1) Quality Measure (Outcome).
- Use of Biopsy After Diagnostic Follow-up with an Eventual Breast Cancer Diagnosis: Positive Predictive Value 3 (PPV3) Quality Measure (Outcome).
- Breast Cancer Screening Episode-Based Cost Measure.
The testing process is an important step in determining whether these measures could eventually be adopted into CMS’ Merit-based Incentive Payment System. Feedback can be provided via the through 11:59pm ET, Feb. 26.
If you have questions, contact Samantha Shugarman, 新澳门六合彩官网® Director of Quality Programs.